EUPATI launches educational toolbox on medicines R&D

Annamarie Dillon | February 04, 2016

The European Patients’ Academy (EUPATI) has announced the launch of its new online Toolbox on Medicines Research & Development. Designed for patients, patient groups, and anyone interested in learning more about medicines R&D, the freely-accessible toolbox includes materials covering drug discovery, clinical development, regulatory affairs, medicines safety, pharmacovigilance, and health technology assessment. The toolbox is available in seven languages: English, French, German, Spanish, Italian, Polish and Russian. It was designed by patients in collaboration with experts from other stakeholder groups such as academia and industry. Users can access a wealth of fact sheets, graphics, slideshows, videos, recorded webinars, print-ready materials as well as a full glossary.

Our vision is that thousands of patient advocates in Europe will leverage the toolbox to enable more meaningful patient involvement and partnership in medicines R&D.’’— Jan Geissler, Director, European Patients‘ Academy.

“The toolbox is a comprehensive, self-explanatory, educational resource that has been built so that learnings on medicines R&D can be developed and shared by patient advocates. It is the result of a long-term, concerted effort by expert stakeholders including patients, researchers and academics. Our vision is that thousands of patient advocates in Europe will leverage the toolbox to enable more meaningful patient involvement and partnership in medicines R&D.’’ says Jan Geissler, Director, European Patients‘ Academy.

The need for the new toolbox is backed up by recent EUPATI research which reveals that pharmaceutical industry personnel believe patients can improve medicines research and development. The study is published in the journal BMJ Open.

Watch a video about the new toolbox.

  • Was this article useful?
Annamarie Dillon's picture
  • Share:
  • Twitter